Clinical Trials Browser

Hodgkin Disease, Lymphoma, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large B-Cell, Diffuse

Phase 2 Study

Lymphoma, Large B-Cell, Diffuse

Hodgkin Disease

Breast Neoplasms

Urinary Bladder Neoplasms

Urinary Bladder Neoplasms

Hodgkin Disease

Pancreatic Neoplasms

Lymphoma, Large B-Cell, Diffuse

Infiltrating Bladder Urothelial Carcinoma

Rhabdoid Tumor

Urinary Bladder Neoplasms

Carcinoma, Non-Small-Cell Lung

Lung Neoplasms

Lung Diseases, Interstitial

Advanced Squamous Non-Small Cell Lung Cancer

Advanced Biliary Tract Carcinoma

Pancreatic Neoplasms

Neoplasm Metastasis, Triple Negative Breast Neoplasms

Urinary Bladder Neoplasms

Resectable Stage IIA to IIIB Non-small Cell Lung Cancer

Advanced Biliary Tract Cancer(BTC)

Pancreatic Neoplasms

Lymphoma, Large B-Cell, Diffuse

Pancreatic Neoplasms

Bile Duct Neoplasms, Cholangiocarcinoma

Urinary Bladder Neoplasms

Carcinoma, Non-Small-Cell Lung

Pancreatic Neoplasms

Nasopharyngeal Carcinoma

Liver Neoplasms

Neoplasm Metastasis

Advanced Biliary Tract Carcinoma

Pancreatic Neoplasms

Pancreatic Neoplasms

Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms

Muscle Invasive Bladder Cancer (MIBC)

Mesothelioma, Malignant, Mesothelioma

Carcinoma, Non-Small-Cell Lung

Gallbladder Neoplasms, Recurrence

Pancreatic Neoplasms

Triple Negative Breast Neoplasms

Pancreatic cancer, adult, Pancreatic Neoplasms

Biliary Tract Neoplasms, Carcinoma

Hodgkin Disease, Recurrence

Cholangiocarcinoma

Clinical Trials

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

A Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer

Efficacy and Safety of Glofitamab Combined With GemOxin the Treatment of Refractory Diffuse Large B-Cell Lymphoma

ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma

The Efficacy and Safety of Trastuzumab Rezetecan (SHR-A1811) in HER2-Low Unresectable/Metastatic Breast Cancer Patients With Visceral Crisis

TRIFECTA

Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer

HOVON164HL

PANCREAS

Low Dose Epcoritamab Plus GemOx in R/R DLBCL

Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations

Study of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT)

Intravesical Gem/Doce in Patients With NMIBC

Nivolumab Plus Cisplatin/Pemetrexed or Cisplatin/Gemcitabine as Induction in Resectable Non-Small Cell Lung Cancer

Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 Therapy

Treatment in Patients With Advanced Non-Small Cell Lung Carcinoma and Interstitial Lung Disease

CECYDE

Camrelizumab Plus Apatinib in Combination With GEMOX (Gemcitabine and Oxaliplatin ) in Patients With Locally Advanced Biliary Tract Cancer

ZN-c3 + Gemcitabine in Pancreatic Cancer

ToPCourT

Phase 2 Study of Pembrolizumab in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy

An Open Label, Randomized Study of Neoadjuvant Nivolumab and Chemotherapy, With or Without Sub-ablative Stereotactic Body Radiation Therapy, for Resectable Stage IIA to IIIB Non-small Cell Lung Cancer

NOBLE

QL1706 Plus Chidamide, AG as First-line Treatment for Metastatic Pancreatic Cancer

Epcoritamab, Rituximab, Gemcitabine and Oxaliplatin (R-GemOx) as Salvage Therapy Before Autologous Stem Cell Transplant for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Paricalcitol and Hydroxychloroquine in Combination With Gemcitabine and Nab-Paclitaxel for Advanced Pancreatic Cancer

Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)

MAGNATE-S

Intravesical Recombinant BCG Followed by Perioperative Chemo-immunotherapy for Patients With MIBC

Reduced-dose Carboplatin-doublet-chemotherapy + Cemiplimab vs Cemiplimab Monotherapy in Treatment Naive Older and Frail Patients With Metastatic NSCLC With PD-L1 <50%

A Phase II Randomized Study of Gemcitabine and Nab-paclitaxel in Combination With S- 1/LV (GASL) or Oxaliplatin (GAP) as First-line Treatment for Metastatic Pancreatic Cancer

SBRT Combined With PD-1 Antibody and Chemotherapy in Oligometastatic Nasopharyngeal Carcinoma

A Phase II Study of Single Tremelimumab With Regular Interval Durvalumab Plus Gemcitabine and Cisplatin in Locally Advanced Unresectable/Metastatic Combined Hepatocellular-cholangiocarcinoma

SWITCH

TACTIC

PANC

STARPAC2

A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer

Pancreas

BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma

HARBOR

Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma

ctDNA Lung RCT

A Study of Different Dosing Schedules of Selumetinib With Cisplatin/Gemcitabine (CIS/GEM) Versus CIS/GEM Alone in Biliary Cancer

Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic Cancer

High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer

ACPC

Perioperative Gemcitabine, Cisplatin, and Pembrolizumab in Potentially Resectable Biliary Tract Cancers

Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma

Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extrahepatic Cholangiocarcinoma